Environmental Justice, Toxicology and Politics
Journal Title: Advances in Clinical Toxicology - Year 2022, Vol 7, Issue 1
Abstract
The Earth and all its inhabitants, including humans, regardless of color, race, income level, or nationality, should be treated with respect as to the implementation and / or enforcement of environmental policies, laws or imposed regulations. Climate change and contaminants can strip an urban community from their basic living needs, and a subsistence community from depletion of natural survival resources. This short commentary addresses that all people should have access to the decision making processes of environmental and health hazards, assessment of legacy toxins and risk management decisions in order that every community worldwide can maintain sustainability through ecological balance.
Authors and Affiliations
Dainowski BH* and Duffy LK
Toxicological Diagnosis of Severe Neutropenia Due to Levamisole
Introduction: Levamisole toxic syndrome may include several effects, such as bone marrow suppression, severe agranulocytosis, neurological symptoms, or cutaneous vasculitis. Methodology: This report emphasizes the impo...
Methyl Mercury, Adipokines, 3T3-L1 Cells and Diabetes
Diabetes is a contributor to morbidity across the globe and is often associated with obesity and metabolic syndrome. In addition to genetic and lifestyle factors, environmental factors such as metals and persistent orga...
QSAR Studies on Some Sulfonamides as Antidiabetic Agents
The need for antidiabetic agents is growing day by day in pharmaceutical industry to find novel, potent and more specialized class of medicine. To address the need we have evaluated a set of sulphonamide drugs for their...
Epidemiology of Pesticides in Developing Countries
Chemical pesticides are group of substances of different classes according to their target species (Eg. herbicides and insecticides), that are created for eradication and control of pests. A global trend of transition f...
Importance of Orphan Drugs Needs More Attention in Future
The orphan drugs or products were not very economically beneficial for pharmaceutical industry due to less number of patients. However, these rare diseases have no any satisfactory treatment in the markets. Currently aft...